In a subsequent cohort study, we will compare the survival rate of two groups of ovarian cancer patients (high TNFRSF6B expression and low TNFRSF6B expression), and the exact mechanism by which the TNF-α/TNFRSF6B signaling pathway inhibits ovarian cancer. This evidence concerns the gene TNFRSF6B and ovarian carcinoma.